Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaojun Wu

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 4, 2022
Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathwaySiyuan Shen, Gaojun Wu, Wu Luo, et al.
Iscience|July 17, 2023
Erratum: Inflammation conditional genome editing mediated by the CRISPR-Cas9 systemTingting Yuan, Honglin Tang, Xiaojie Xu, et al.
Iscience|June 1, 2023
Inflammation conditional genome editing mediated by the CRISPR-Cas9 systemTingting Yuan, Honglin Tang, Xiaojie Xu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 2, 2021
Toll-like receptor 2 signaling deficiency in cardiac cells ameliorates Ang II-induced cardiac inflammation and remodelingShiju Ye, Ke Lin, Gaojun Wu, et al.
Phytotherapy Research : PTR|September 30, 2022
Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signalingNa Yang, Chunpeng Zou, Wu Luo, et al.
International Immunopharmacology|April 14, 2023
Tussilagone attenuates atherosclerosis through inhibiting MAPKs-mediated inflammation in macrophagesSirui Shen, Zhuqi Huang, Liming Lin, et al.
Phytotherapy Research : PTR|February 6, 2024
Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signalingNa Yang, Chunpeng Zou, Wu Luo, et al.
Phytotherapy Research : PTR|November 24, 2022
Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammationYanghao Chen, Wante Lin, Pan Chen, et al.
Toxicology and Applied Pharmacology|March 13, 2019
Blockage of ROS and MAPKs-mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathyWu Luo, Yiyi Jin, Gaojun Wu, et al.
Aging|January 26, 2021
Myeloid differentiation 2 deficiency attenuates AngII-induced arterial vascular oxidative stress, inflammation, and remodelingShushi Huang, Shengban You, Jinfu Qian, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 4, 2022
Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathwaySiyuan Shen, Gaojun Wu, Wu Luo, et al.
Iscience|July 17, 2023
Erratum: Inflammation conditional genome editing mediated by the CRISPR-Cas9 systemTingting Yuan, Honglin Tang, Xiaojie Xu, et al.
Iscience|June 1, 2023
Inflammation conditional genome editing mediated by the CRISPR-Cas9 systemTingting Yuan, Honglin Tang, Xiaojie Xu, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 2, 2021
Toll-like receptor 2 signaling deficiency in cardiac cells ameliorates Ang II-induced cardiac inflammation and remodelingShiju Ye, Ke Lin, Gaojun Wu, et al.
Phytotherapy Research : PTR|September 30, 2022
Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signalingNa Yang, Chunpeng Zou, Wu Luo, et al.
International Immunopharmacology|April 14, 2023
Tussilagone attenuates atherosclerosis through inhibiting MAPKs-mediated inflammation in macrophagesSirui Shen, Zhuqi Huang, Liming Lin, et al.
Phytotherapy Research : PTR|February 6, 2024
Correction to: Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signalingNa Yang, Chunpeng Zou, Wu Luo, et al.
Phytotherapy Research : PTR|November 24, 2022
Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammationYanghao Chen, Wante Lin, Pan Chen, et al.
Toxicology and Applied Pharmacology|March 13, 2019
Blockage of ROS and MAPKs-mediated inflammation via restoring SIRT1 by a new compound LF10 prevents type 1 diabetic cardiomyopathyWu Luo, Yiyi Jin, Gaojun Wu, et al.
Aging|January 26, 2021
Myeloid differentiation 2 deficiency attenuates AngII-induced arterial vascular oxidative stress, inflammation, and remodelingShushi Huang, Shengban You, Jinfu Qian, et al.
Pageof 7